Abstract
Background/Aims
We investigated the five-year survival outcomes of a large cohort of hepatocellular carcinoma (HCC) patients who were treated at a single institute, and this is a follow-up study of a previous report. Methods: Nine hundred four HCC patients who were treated at the National Cancer Center Korea were enrolled and they were followed till February 2007. Results: The mean age of the patients was 56.0 years and 731 patients were male. Six hundred seventy-seven (74.9%) patients died and the overall 5-year survival rate (5-YSR) was 23.9%. The 5-YSRs of the patients with modified UICC stage I, II and III were 61.2%, 54.4% and 18.4%, respectively, and the median survival time was 4.3 and 3.7 months for the stage IVa and IVb patients, respectively. For the analysis of the treatment modality, surgical resection showed significantly better outcomes for the five-year survival as compared with transcatheter arterial chemoembolization (TACE) for Child-Pugh A patients with modified UICC stage I or II disease (80.1% vs 52.8%, respectively, P<.001), or stage III disease (60.7% vs 17.0%, respectively, P<.001). For patients with advanced stage IVb disease, TACE, systemic chemotherapy and radiotherapy increased the median survival period more than conservative management for the Child-Pugh class A patients. The serum alpha-fetoprotein level, portal vein tumor thrombosis, the Child-Pugh class, the tumor stage, the tumor type and symptoms were related to the prognosis. Conclusions: This study presented, for the first time, the 5-YSRs of a cohort of HCC patients. (Korean J Hepatol 2007;13:530-542)
Citations
Citations to this article as recorded by
- Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis
Ros Wade, Emily South, Sumayya Anwer, Sahar Sharif-Hurst, Melissa Harden, Helen Fulbright, Robert Hodgson, Sofia Dias, Mark Simmonds, Ian Rowe, Patricia Thornton, Alison Eastwood
Health Technology Assessment.2023; : 1. CrossRef - Clinicopathological characteristics of TERT promoter mutation and telomere length in hepatocellular carcinoma
Hye Won Lee, Tae In Park, Se Young Jang, Soo Young Park, Won-Jin Park, Soo-Jung Jung, Jae-Ho Lee
Medicine.2017; 96(5): e5766. CrossRef - Association study of two inflammation-related polymorphisms with susceptibility to hepatocellular carcinoma: a meta-analysis
Jiajing Liu, Bo Xie, Shuilian Chen, Feng Jiang, Wei Meng
BMC Medical Genetics.2014;[Epub] CrossRef - Clinical outcomes of a cohort series of patients with hepatocellular carcinoma in a hepatitis B virus‐endemic area
Hee‐Won Kwak, Joong‐Won Park, Byung‐Ho Nam, Ami Yu, Sang Myung Woo, Tae Hyun Kim, Seong Hoon Kim, Young Hwan Koh, Hyun Beom Kim, Sang Jae Park, Woo Jin Lee, Eun Kyung Hong, Chang‐Min Kim
Journal of Gastroenterology and Hepatology.2014; 29(4): 820. CrossRef - Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population
Won Hee Kim, Kyung Tae Min, Young Joo Jeon, Chang-Il Kwon, Kwang Hyun Ko, Pil Won Park, Sung Pyo Hong, Kyu Seong Rim, Sung Won Kwon, Seong Gyu Hwang, Nam Keun Kim
Gene.2012; 504(1): 92. CrossRef - Analysis of prognostic factors and 5-year survival rate in patients with hepatocellular carcinoma: a single-center experience
Sang Seok Lee, Hyun Sung Shin, Hyung Joon Kim, Su Jin Lee, Hyun Suk Lee, Kyung Hee Hyun, Yong Hyun Kim, Byoung Woon Kwon, Jin Hyung Han, Hoon Choi, Bae Hwan Kim, Joon Hyuk Lee, Ha Yan Kang, Hyun Deok Shin, Il Han Song
The Korean Journal of Hepatology.2012; 18(1): 48. CrossRef - Therapeutic effect of high-intensity focused ultrasound combined with transarterial chemoembolisation for hepatocellular carcinoma <5 cm: comparison with transarterial chemoembolisation monotherapy—preliminary observations
J Kim, D J Chung, S E Jung, S H Cho, S-T Hahn, J M Lee
The British Journal of Radiology.2012; 85(1018): e940. CrossRef - Transarterial Chemoembolization for Hepatocellular Carcinoma over Three Decades: Current Progress and Perspective
K. Takayasu
Japanese Journal of Clinical Oncology.2012; 42(4): 247. CrossRef - Chemoembolization for Hepatocellular Carcinoma: Multivariate Analysis of Predicting Factors for Tumor Response and Survival in a 362-Patient Cohort
Hong Tao Hu, Jin Hyoung Kim, Lim-Sick Lee, Kyung-Ah Kim, Gi-Young Ko, Hyun-Ki Yoon, Kyu-Bo Sung, Dong Il Gwon, Ji Hoon Shin, Ho-Young Song
Journal of Vascular and Interventional Radiology.2011; 22(7): 917. CrossRef - Therapeutic Effect of Transcatheter Arterial Embolization for Hypervascular Hepatocellular Carcinoma: Web-based Multicenter Analysis
Jun Hyun Baik, Kyung Sup Song, Joon Koo Han, Sung Wook Choo, Sohee Park, Hyun-Joo Kong, Sungwook Shin, Kwang-Hun Lee, Jae Kyu Kim
Journal of the Korean Society of Radiology.2011; 64(6): 557. CrossRef - Phase I Dose-Escalation Study of Proton Beam Therapy for Inoperable Hepatocellular Carcinoma
Tae Hyun Kim, Joong-Won Park, Yeon-Joo Kim, Bo Hyun Kim, Sang Myung Woo, Sung Ho Moon, Sang Soo Kim, Young-Hwan Koh, Woo Jin Lee, Sang Jae Park, Joo-Young Kim, Dae Yong Kim, Chang-Min Kim
Cancer Research and Treatment.1970; 47(1): 34. CrossRef
